5 Key Takeaways

• 1

  Esophageal adenocarcinoma (EAC) may arise through a shared biological pathway linked to Barrett’s esophagus (BE), even without BE being identified.

• 2

  The study analyzed 3,100 EAC patients from 25 UK centers, revealing similar demographic and risk profiles in those with and without detectable BE.

• 3

  Genomic analyses showed significant overlap in key driver mutations and mutational burden between BE-positive and BE-negative tumors.

• 4

  Markers of intestinal metaplasia were found in tumors lacking histologically identifiable BE, indicating persistence of precursor biology.

• 5

  The absence of detectable BE does not rule out underlying precursor changes, suggesting molecular approaches may enhance early detection.